A 38-year-old woman presents to the oncology clinic with a 2-year history of recurrent breast cancers—first a left-sided invasive ductal carcinoma diagnosed at age 36, now a right-sided lesion at age 38. Family history reveals her mother died of ovarian cancer at age 42, and her maternal grandmother had breast cancer at age 45. Genetic testing confirms a heterozygous frameshift mutation in exon 11 of the BRCA1 gene. Immunohistochemistry on her current tumor shows loss of p53 expression. Which of the following best explains the aggressive behavior and bilateral presentation in this patient?

Explanation

## Tumor Suppressor Gene Inactivation in BRCA1-Associated Breast Cancer ### The Two-Hit Hypothesis in Action **Key Point:** BRCA1 is a tumor suppressor gene that follows Knudson's two-hit hypothesis. The patient inherited one mutant BRCA1 allele (germline mutation), and in her tumor cells, the remaining wild-type allele is lost through somatic mutation or deletion. This loss of both copies of BRCA1 severely impairs homologous recombination (HR) DNA repair. ### Why Bilateral and Aggressive? **Clinical Pearl:** Every cell in this patient's body carries the inherited BRCA1 mutation. This creates a "field effect"—all breast epithelial cells are predisposed. The additional somatic loss of p53 (shown by immunohistochemistry loss of expression) removes the G1/S checkpoint, allowing cells with unrepaired DNA damage to progress through the cell cycle and accumulate further mutations. **High-Yield:** The combination of: 1. **Homozygous BRCA1 loss** (germline + somatic) → defective HR repair → genomic instability 2. **Somatic TP53 mutation** → loss of p53-mediated apoptosis and cell-cycle arrest → cells with DNA damage survive and proliferate This dual inactivation explains the aggressive phenotype and increased risk of bilateral disease. ### Molecular Mechanism | Gene | Function | Status in This Patient | Consequence | |------|----------|------------------------|-------------| | BRCA1 | Homologous recombination repair | Homozygous loss (germline + somatic) | Defective HR; accumulation of DSBs | | TP53 | G1/S checkpoint; apoptosis | Somatic mutation/loss | Cells with DNA damage escape apoptosis | | Result | — | — | Aggressive tumor with high mutation burden | ### Why Germline BRCA1 Mutation Increases Bilateral Risk Each breast cell already carries one defective BRCA1 allele. The probability that a second somatic event will knock out the remaining allele is significantly higher than in the general population, leading to: - Earlier age of onset - Bilateral and multifocal disease - Higher lifetime cancer risk **Mnemonic:** **BRCA + p53 = BIG TROUBLE** — Two critical tumor suppressors lost = aggressive, early-onset, bilateral cancers. [cite:Robbins 10e Ch 7]